MYC and Miyoshi myopathy: Apart from these main translocations, chromosomal translocations involving MYC (and leading to its overexpression) can be found as secondary genomic events in 15–20% of patients with newly diagnosed MM, but only in 3–4% of patients with MGUS or SMM [19,47,48].